Varicella-zoster vaccine virus: Evolution in action

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 1, 2007, Pages 7-8

  Cohen, Jeffrey I ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; AMINO ACID; CYTOSINE; DOUBLE STRANDED DNA; GUANIDINE; NUCLEOTIDE; THYMIDINE; VARICELLA ZOSTER VACCINE;

DRUG SAFETY; ENDOTHELIUM CELL; FIBROBLAST; GENE SEQUENCE; GENETIC STABILITY; GENOTYPE; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; OKA VACCINE VIRUS; ORF62 GENE; PRIORITY JOURNAL; RASH; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINE VIRUS; VARICELLA ZOSTER VIRUS; VIRUS GENE; VIRUS INFECTION; VIRUS REACTIVATION; VIRUS STRAIN;

ANIMALS; CHICKENPOX VACCINE; CHILD; EVOLUTION, MOLECULAR; EXANTHEMA; HERPESVIRUS 3, HUMAN; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; VACCINATION;

EID: 33846099987     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0610016103     Document Type: Note

References (20)

1. Quinlivan ML, Gershon AA, Al Bassam MM, Steinberg SP, LaRussa P, Nichols RA, Breuer J (2007) Proc Natl Acad Sci USA 104:208-212.
2. Muir WB, Nichols R, Breuer J (2002) J Virol 76:1971-1979.
3. Peters GA, Tyler SD, Grose C, Severini A, Gray MJ, Upton C, Tipples GA (2006) J Virol 80:9850-9860.
4. Straus SE, Reinhold W, Smith HA, Ruyechan WT, Henderson DK, Blase RM, Hay J (1984) N Engl J Med 311:1362-1364.
5. Williams DL, Gershon AA, Gelb LD, Spraker MK, Steinberg S, Ragab AH (1985) J Pediatr 106:259-261.
6. Tana Y, Scott FT, Parker SP, Syndercombe Court D, Quinlivan ML, Breuer J (2006) Clin Infect Dis 43:1301-1303.
7. Grose C, Tyler S, Peters G, Hiebert J, Stephens GM, Ruyechan WT, Jackson W, Storlie J, Tipples GA (2004) J Virol 78:6799-6807.
8. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T (1974) Lancet 2:1288-1290.
9. Hayakawa Y, Torigoe S, Shiraki K, Yamanishi K, Takahashi M (1984) J Infect Dis 149:956-963.
10. Shiraki K, Yoshida Y, Asano Y, Yamanishi K, Takahashi M (2003) J Infect Dis 188:1875-1877.
11. Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM (1998) J Virol 72:965-974.
12. Gomi Y, Sunamachi H, Mori Y, Nagaike K, Takahashi M, Yamanishi K (2002) J Virol 76:11447-11459.
13. Sharrar RG, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA (2000) Vaccine 19:916-923.
14. Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, Krause PR (2000) J Am Med Assoc 284:1271-1279.
15. Hughes P, LaRussa P, Pearce JM, Lepow M, Steinberg S, Gershon A (1994) J Pediatr 124:932-935.
16. Tsolia M, Gershon AA, Steinberg SP, Gelb L (1990) J Pediatr 116:184-189.
17. Quinlivan ML, Gershon AA, Steinberg SP, Breuer J (2004) J Infect Dis 190:793-796.
18. Quinlivan MA, Gershon AA, Nichols RA, La Russa P, Steinberg SP, Breuer J (2006) J Infect Dis 193:927-930.
19. Davison AJ, Scott JE (1986) J Gen Virol 67:1759-1816.
20. Zerboni L, Hinchliffe S, Sommer MH, Ito H, Besser J, Stamatis S, Cheng J, Distefano D, Kraiouchkine N, Shaw A, Arvin AM (2005) Virology 332:337-346.